Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Weight Loss × Mirtazapine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Anorexia 3 Neoplasms 2 Cachexia 2 Weight Loss 1 Depression 1 Carcinoma, Non-Small-Cell Lung 1 Body Weight 1 Anorexia Nervosa with Significantly Low Body Weight 1

Interventions

anamorelin 2 Tirzepatide 1 Olanzapine 1 Octreotide 1 Nutritionists 1 Nutrition Assessment 1 Mirtazapine 1 Flurandrenolone 1 Exercise 1 EOM613 1 Diet, Carbohydrate-Restricted 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00832520 2018-04-10

Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

New Mexico Cancer Research Alliance

Phase 2 Terminated

13 enrolled 4 charts

Body Weight, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡